These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 3393143
1. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX. McCluskey SA, Marks GS, Whitney RA, Ortiz de Montellano PR. Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143 [Abstract] [Full Text] [Related]
2. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. McCluskey SA, Whitney RA, Marks GS. Mol Pharmacol; 1989 Oct; 36(4):608-14. PubMed ID: 2811858 [Abstract] [Full Text] [Related]
3. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase. McCluskey SA, Marks GS, Sutherland EP, Jacobsen N, Ortiz de Montellano PR. Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522 [Abstract] [Full Text] [Related]
4. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II. Kimmett SM, Whitney RA, Marks GS. Mol Pharmacol; 1992 Aug; 42(2):307-10. PubMed ID: 1513328 [Abstract] [Full Text] [Related]
5. Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics. Kobus SM, Wong SG, Marks GS. Can J Physiol Pharmacol; 2001 Sep; 79(9):814-21. PubMed ID: 11599783 [Abstract] [Full Text] [Related]
6. Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers. Kimmett SM, Whitney RA, Marks GS. Mol Pharmacol; 1996 Apr; 49(4):676-82. PubMed ID: 8609896 [Abstract] [Full Text] [Related]
7. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Marks GS, Allen DT, Johnston CT, Sutherland EP, Nakatsu K, Whitney RA. Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391 [Abstract] [Full Text] [Related]
8. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver. Riddick DS, Park SS, Gelboin HV, Marks GS. Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472 [Abstract] [Full Text] [Related]
9. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats. Riddick DS, Park SS, Gelboin HV, Marks GS. Mol Pharmacol; 1990 Jan; 37(1):130-6. PubMed ID: 2405248 [Abstract] [Full Text] [Related]
10. Isolation of an N-alkylprotoporphyrin IX from chick embryo livers following the administration of 3,5-diethoxycarbonyl-1,4-dihydro-4-ethyl-2,6-dimethylpyridine. McCluskey SA, Sutherland EP, Racz WJ, Marks GS. Can J Physiol Pharmacol; 1987 Jul; 65(7):1500-2. PubMed ID: 3664364 [Abstract] [Full Text] [Related]
11. Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents. McCluskey SA, Riddick DS, Mackie JE, Kimmett SM, Whitney RA, Marks GS. Can J Physiol Pharmacol; 1992 Aug; 70(8):1069-74. PubMed ID: 1473038 [Abstract] [Full Text] [Related]
12. Thin-layer chromatographic separation of the ferrochelatase-inhibitory ring A and ring B regioisomers of N-ethylprotoporphyrin from a mixture of the four regioisomers. Kimmett SM, Marks GS. J Pharmacol Toxicol Methods; 1992 Sep; 28(2):113-7. PubMed ID: 1482786 [Abstract] [Full Text] [Related]
13. The apoprotein of cytochrome P450 3A2 does not selectively direct alkylation to one of four pyrrole rings of N-vinylprotoporphyrin IX. McNamee JP, Kobus SM, Marks GS. Can J Physiol Pharmacol; 1996 Aug; 74(8):996-1000. PubMed ID: 8960390 [Abstract] [Full Text] [Related]
14. Synergistic induction of delta-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine . Mackie JE, Marks GS. Biochem Pharmacol; 1989 Jul 01; 38(13):2169-73. PubMed ID: 2735955 [Abstract] [Full Text] [Related]
15. Comparison of the effects of 3-ethoxycarbonyl-1,4-dihydro-2,4-dimethylpyridine and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity and heme biosynthesis in chick embryo liver cells in culture. Marks GS, Allen DT, Sutherland EP, McCluskey SA, Whitney RA. Can J Physiol Pharmacol; 1986 Apr 01; 64(4):483-6. PubMed ID: 3730932 [Abstract] [Full Text] [Related]
16. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Cole SP, Whitney RA, Marks GS. Mol Pharmacol; 1981 Sep 01; 20(2):395-403. PubMed ID: 7300820 [No Abstract] [Full Text] [Related]
18. Gender differences in N-alkyl protoporphyrin IX production in rats after the administration of porphyrinogenic xenobiotics. Wong SG, Kobus SM, McNamee JP, Marks GS. Drug Metab Dispos; 1998 Aug 01; 26(8):739-44. PubMed ID: 9698287 [Abstract] [Full Text] [Related]